Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 6, 1997, Pages 889-893

  De Logu, Alessandro ^a,b   Fadda, Anna Maria ^b   Anchisi, Carlo ^b   Maccioni, Anna Maria ^b   Sinico, Chiara ^b   Schivo, Maria Laura ^a   Alhaique, Franco ^c  

^a Dipto Sci Chirurgiche T   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; KETOCONAZOLE; MICONAZOLE; PHOSPHOLIPID;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; DRUG FORMULATION; FUNGICIDAL ACTIVITY; NONHUMAN;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG CARRIERS; KETOCONAZOLE; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; PHOSPHOLIPIDS;

EID: 0031464239     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.6.889     Document Type: Article

References (10)

1. Berenguer, J., Munoz, P., Parras, F., Fernandez-Baca, V., Hernandez-Sampelayo, T. & Bouza, E. (1994). Treatment of deep mycoses with liposomal amphotericin B. European Journal of Clinical Microbiology and Infectious Diseases 13, 504-7.
2. Caillot, D., Casasnovas, O., Solary, E., Chavanet, P., Bonnotte, B., Reny, G. et al. (1993). Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidemia in neutropenic patients. Journal of Antimicrobial Chemotherapy 31, 161-9.
3. Ralph, E. D., Khazindar, A. M., Barber, K. R. & Grant, C. W. M. (1991). Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentrations susceptibility studies and time kill curves. Antimicrobial Agents and Chemotherapy 35, 188-91.
4. Singh, M., Singh, M. P., Maiti, S. N., Gandhi, A., Micetich, R. G. & Atwal, H. (1993). Preparations of liposomal fluconazole and their in vitro antifungal activity. Microencapsulation 10, 229-36.
5. Szoka, F. C., Milholland, D. & Barza, M. (1987). Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. Antimicrobial Agents and Chemotherapy 31, 421-9.
6. Alhaique, F., Anchisi, C., Fadda, A. M., Maccioni, A. M. & Travagli, V. (1993). Miconazole, ketoconazole and liposomal preparations: a reserved-phase HPLC determination. Acta Technologiae Legis Medicamenti 4, 169-75.
7. Hopfer, R. L, Mills, K., Mehta, R., Lopez-Berestein, G., Fainstein, V. & Juliano, R. L. (1984). In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B. Antimicrobial Agents and Chemotherapy 25, 387-9.
8. Pahls, S. & Schaffner, A. (1994). Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis. Journal of Infectious Diseases 169, 1057-61.
9. Janoff, A. S., Boni, L. T., Popescu, M. C., Minchey, S. R., Cullis, P. R., Madden, T. D. et al. (1988). Unusually lipid structures selectively reduce the toxicity of amphotericin B. Proceedings of the National Academy of Sciences of the United States of America 85, 6122-6.
10. Wasan, K. M., Brazeau, G. A., Keyhani, A., Hayman, A. C. & Lopez-Berestein, G. (1993). Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins. Antimicrobial Agents and Chemotherapy 37, 246-50.